Medical Attendance for Lower Urinary Tract Symptoms Is Associated with Subsequent Increased Risk of Outpatient Visits and Hospitalizations Based on a Nationwide Population-Based Database

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Wu, Ming Ping ^a,b   Weng, Shih Feng ^b,c   Hsu, Ya Wen ^b,c   Wang, Jhi Joung ^c   Kuo, Hann Chorng ^d  

^a Chi Mei Foundation Hospital   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; EMERGENCY WARD; FAMILY MEDICINE; FEMALE; GENERAL PRACTICE; GROUPS BY AGE; GYNECOLOGY; HOSPITALIZATION; HUMAN; INCIDENCE; INTERNAL MEDICINE; LOWER URINARY TRACT SYMPTOM; MALE; NEUROLOGY; NEUROSURGERY; OPHTHALMOLOGY; ORTHOPEDICS; OTORHINOLARYNGOLOGY; OUTPATIENT CARE; PSYCHIATRY; SOCIAL PARTICIPATION; TAIWAN; UROLOGY; AMBULATORY CARE; COHORT ANALYSIS; FACTUAL DATABASE; HEALTH SERVICES RESEARCH; LOWER URINARY TRACT SYMPTOMS; MIDDLE AGED; OUTPATIENT; PREVALENCE; PUBLIC HEALTH; RISK; STATISTICS AND NUMERICAL DATA; URETHRAL DISEASES; URINARY BLADDER DISEASES;

ADULT; AGED; AMBULATORY CARE; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HEALTH SERVICES RESEARCH; HOSPITALIZATION; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; OUTPATIENTS; PREVALENCE; RISK; TAIWAN; URETHRAL DISEASES; URINARY BLADDER DISEASES;

EID: 84874593417     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057825     Document Type: Article

References (37)

1. Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, et al. (2010) Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 29: 213-240.
2. Chen GD, Lin TL, Hu SW, Chen YC, Lin LY, (2003) Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women. Neurourol Urodyn 22: 109-117.
3. Lee YS, Lee KS, Jung JH, Han DH, Oh SJ, et al. (2011) Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study. World J Urol 29: 185-190.
4. Irwin DE, Milsom I, Kopp Z, Abrams P, Artibani W, et al. (2009) Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol 56: 14-20.
5. Malmsten UG, Molander U, Peeker R, Irwin DE, Milsom I, (2010) Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years. Eur Urol 58: 149-156.
6. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P, (2011) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 108: 1132-1138.
7. Wu MP, Hsu YW, Weng SF, Ho CH, Wang JJ, et al. (2013) The healthcare-seeking prevalence of lower urinary tract symptoms among National Health Insurance enrollees in Taiwan, 2000-2009. Urology 2013 81: 61-65.
8. Charness N, (2008) Aging and human performance. Hum Factors 50: 548-555.
9. Lunenfeld B, (2008) An Aging World-demographics and challenges. Gynecol Endocrinol 24: 1-3.
10. Wehrberger C, Temml C, Gutjahr G, Berger I, Rauchenwald M, et al. (2011) Is there an association between lower urinary tract symptoms and cardiovascular risk in men? A cross sectional and longitudinal analysis. Urology 78: 1063-1067.
11. Kannan H, Radican L, Turpin RS, Bolge SC, (2009) Burden of illness associated with lower urinary tract symptoms including overactive bladder/urinary incontinence. Urology 74: 34-38.
12. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, et al. (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20: 327-336.
13. Terai A, Matsui Y, Ichioka K, Ohara H, Terada N, et al. (2004) Comparative analysis of lower urinary tract symptoms and bother in both sexes. Urology 63: 487-491.
14. Irwin DE, Milsom I, Kopp Z, Abrams P, (2008) Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol 53: 1029-1037.
15. Hu TW, Wagner TH, (2005) Health-related consequences of overactive bladder: an economic perspective. BJU Int 96Suppl 1: 43-45.
16. Wu MP, Huang KH, Long CY, Huang KF, Yu KJ, et al. (2008) The distribution of different surgical types for female stress urinary incontinence among patients' age, surgeons' specialties and hospital accreditations in Taiwan: a descriptive 10-year nationwide study. Int Urogynecol J Pelvic Floor Dysfunct 19: 1639-1646.
17. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, et al. (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185: 1793-1803.
18. Yazici H, (2012) Beware of registries for their biases. Bull NYU Hosp Jt Dis 70: 95-98.
19. Heaton JP, (2006) Lower urinary tract disease: what are we trying to treat and in whom? Br J Pharmacol 147Suppl 2: S2-13.
20. Chapple CR, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, et al. (2008) Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol 54: 563-569.
21. Ng CF, Wong A, Li ML, Chan SY, Mak SK, et al. (2007) The prevalence of cardiovascular risk factors in male patients who have lower urinary tract symptoms. Hong Kong Med J 13: 421-426.
22. Michel MC, Heemann U, Schumacher H, Mehlburger L, Goepel M, (2004) Association of hypertension with symptoms of benign prostatic hyperplasia. J Urol 172: 1390-1393.
23. Parsons JK, (2010) Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors. Curr Bladder Dysfunct Rep 5: 212-218.
24. Ponholzer A, Temml C, Wehrberger C, Marszalek M, Madersbacher S, (2006) The association between vascular risk factors and lower urinary tract symptoms in both sexes. Eur Urol 50: 581-586.
25. Coyne KS, Sexton CC, Kopp ZS, Ebel-Bitoun C, Milsom I, et al. (2011) The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int 108: 1459-1471.
26. Tai HC, Chung SD, Ho CH, Tai TY, Yang WS, et al. (2010) Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab 95: 1143-1150.
27. Chung SD, Liu HT, Lin H, Kuo HC, (2011) Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn 30: 417-420.
28. Liao CH, Chung SD, Kuo HC, (2011) Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment. Urology 78: 1373-1378.
29. Hsiao SM, Lin HH, Kuo HC, (2012) The role of serum C-reactive protein in women with lower urinary tract symptoms. Int Urogynecol J 23: 935-940.
30. Liu HT, Lin H, Kuo HC, (2011) Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Neurourol Urodyn 30: 1525-1529.
31. Karatas OF, Bayrak O, Cimentepe E, Unal D, (2010) An insidious risk factor for cardiovascular disease: benign prostatic hyperplasia. Int J Cardiol 144: 452.
32. Rotar M, Blagus R, Jeromel M, Skrbec M, Trsinar B, et al. (2011) Stroke patients who regain urinary continence in the first week after acute first-ever stroke have better prognosis than patients with persistent lower urinary tract dysfunction. Neurourol Urodyn 30: 1315-1318.
33. Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, et al. (2009) The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int 103Suppl 3: 4-11.
34. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, et al. (2008) The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 101: 1388-1395.
35. Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L, (2006) Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int 97: 96-100.
36. Girman CJ, Jacobsen SJ, Tsukamoto T, Richard F, Garraway WM, et al. (1998) Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology 51: 428-436.
37. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, et al. (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61: 37-49.